Reverse Transcriptase Inhibitors [clinicaltrials_resource:9e1536af6b9d95e1c13f94cef30497a0]
A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells [clinicaltrials:NCT00000822]A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women [clinicaltrials:NCT00000864]The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children [clinicaltrials:NCT00000865]A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies [clinicaltrials:NCT00000869]Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection [clinicaltrials:NCT00000872]A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART [clinicaltrials:NCT00000874]A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants [clinicaltrials:NCT00000878]Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects [clinicaltrials:NCT00000882]Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320 [clinicaltrials:NCT00000885]Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children [clinicaltrials:NCT00000893]A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection [clinicaltrials:NCT00000895]A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients [clinicaltrials:NCT00000896]A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women [clinicaltrials:NCT00000897]A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients [clinicaltrials:NCT00000899]Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children [clinicaltrials:NCT00000901]Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen [clinicaltrials:NCT00000903]A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children [clinicaltrials:NCT00000913]A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks [clinicaltrials:NCT00000914]A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood [clinicaltrials:NCT00000916]A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure [clinicaltrials:NCT00000918]A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection [clinicaltrials:NCT00000919]A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART) [clinicaltrials:NCT00000922]A Study to Compare Two Different Anti-HIV Drug Regimens [clinicaltrials:NCT00000924]A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible [clinicaltrials:NCT00000939]Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV [clinicaltrials:NCT00000940]Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs [clinicaltrials:NCT00001083]A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients [clinicaltrials:NCT00001084]A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients [clinicaltrials:NCT00001085]A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients [clinicaltrials:NCT00001086]The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs [clinicaltrials:NCT00001087]Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens [clinicaltrials:NCT00001091]A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir [clinicaltrials:NCT00001095]Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems [clinicaltrials:NCT00001097]The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive Patients [clinicaltrials:NCT00001102]A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses [clinicaltrials:NCT00001108]Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children [clinicaltrials:NCT00001118]Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV [clinicaltrials:NCT00001119]A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly [clinicaltrials:NCT00001122]Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination [clinicaltrials:NCT00001132]Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor [clinicaltrials:NCT00001826]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Reverse Transcriptase Inhibitors [clinicaltrials_resource:9e1536af6b9d95e1c13f94cef30497a0]
Bio2RDF identifier
9e1536af6b9d95e1c13f94cef30497a0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9e1536af6b9d95e1c13f94cef30497a0
identifier
clinicaltrials_resource:9e1536af6b9d95e1c13f94cef30497a0
title
Reverse Transcriptase Inhibitors
@en
type
label
Reverse Transcriptase Inhibito ...... 536af6b9d95e1c13f94cef30497a0]
@en